TOMBOLINI, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 1.555
EU - Europa 802
AS - Asia 634
SA - Sud America 131
Continente sconosciuto - Info sul continente non disponibili 42
AF - Africa 19
OC - Oceania 3
Totale 3.186
Nazione #
US - Stati Uniti d'America 1.502
SG - Singapore 339
RU - Federazione Russa 187
IE - Irlanda 170
IT - Italia 133
BR - Brasile 117
CN - Cina 115
DE - Germania 95
VN - Vietnam 62
SE - Svezia 57
GB - Regno Unito 41
HK - Hong Kong 40
CA - Canada 35
UA - Ucraina 25
FI - Finlandia 24
TR - Turchia 18
FR - Francia 17
BE - Belgio 13
ES - Italia 12
IN - India 12
ZA - Sudafrica 11
JP - Giappone 9
AR - Argentina 7
BD - Bangladesh 6
CZ - Repubblica Ceca 6
IQ - Iraq 6
PH - Filippine 6
MX - Messico 5
PL - Polonia 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
NL - Olanda 4
AU - Australia 3
DK - Danimarca 3
EU - Europa 3
ID - Indonesia 3
LT - Lituania 3
PK - Pakistan 3
BY - Bielorussia 2
CO - Colombia 2
JM - Giamaica 2
MA - Marocco 2
SV - El Salvador 2
UY - Uruguay 2
UZ - Uzbekistan 2
AT - Austria 1
BF - Burkina Faso 1
BS - Bahamas 1
BW - Botswana 1
CL - Cile 1
EE - Estonia 1
ET - Etiopia 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
IL - Israele 1
JO - Giordania 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
VE - Venezuela 1
Totale 3.147
Città #
Chandler 192
Singapore 182
Dublin 170
Dallas 164
San Jose 152
Ashburn 136
Jacksonville 95
Council Bluffs 54
Santa Clara 53
Ann Arbor 45
Hong Kong 40
New York 40
Munich 37
The Dalles 37
Boardman 32
Rome 25
Los Angeles 23
Beijing 22
Wilmington 21
Lawrence 20
Princeton 20
Hanoi 19
Moscow 18
Ho Chi Minh City 17
Milan 16
São Paulo 16
Bremen 15
Orem 14
Brussels 13
Columbus 13
Nanjing 12
Helsinki 11
Izmir 10
Montreal 10
Stockholm 8
Tokyo 8
Woodbridge 8
Johannesburg 7
Seattle 7
Turku 7
Atlanta 6
Brno 6
Brooklyn 6
Changsha 6
Denver 6
Frankfurt am Main 6
Haiphong 6
Houston 6
L'aquila 6
Manchester 6
Phoenix 6
San Mateo 6
Shenyang 6
Chennai 5
Des Moines 5
Falls Church 5
Grafing 5
Kunming 5
Lappeenranta 5
Warsaw 5
Belo Horizonte 4
Berlin 4
Bologna 4
Chicago 4
Falkenstein 4
Mountain View 4
Nanchang 4
North Bergen 4
Poplar 4
San José 4
Shanghai 4
Toronto 4
Washington 4
Arlington 3
Birmingham 3
Boston 3
Charleston 3
Da Nang 3
Guangzhou 3
Las Vegas 3
Lauterbourg 3
London 3
Madrid 3
Mexico City 3
Mumbai 3
Norwalk 3
Ottawa 3
Palermo 3
Philadelphia 3
Pierre 3
Quezon City 3
San Francisco 3
Ankara 2
Baghdad 2
Cape Town 2
Charlotte 2
Curitiba 2
Dearborn 2
Düsseldorf 2
Guarulhos 2
Totale 2.027
Nome #
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 217
Moderate hypofractionation in patients with low-risk prostate cancer: Long-term outcomes 189
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 183
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 167
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 165
Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results 160
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 159
New approaches in glioblastoma multiforme: The potential role of immune-check point inhibitors 153
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 150
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo 150
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 148
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 146
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 143
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 142
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis 142
Ms−275 (Entinostat) promotes radio-sensitivity in pax3-foxo1 rhabdomyosarcoma cells 138
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 137
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) 135
Phase 2 of coronavirus disease (COVID-19) and head and neck cancer: An action plan 121
Sinonasal Undifferentiated Carcinoma in a Patient Previously Treated for an Intestinal-Type Adenocarcinoma: Metachronous Neoplasms or Recurrence of a Different Tumor Type? 94
Resilience in Radiotherapy Services During the COVID-19 Emergency: Collaboration Between the Regional Radiation Oncology Departments of Lazio, Abruzzo and Molise 83
Targeted molecular therapy in glioblastoma 64
Totale 3.186
Categoria #
all - tutte 12.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.748


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022107 0 0 0 9 3 9 7 7 18 6 8 40
2022/2023491 30 42 6 80 33 52 0 24 200 6 12 6
2023/2024138 6 14 11 5 6 60 9 2 0 5 6 14
2024/2025629 18 10 30 60 89 69 82 48 115 19 50 39
2025/20261.138 69 88 150 160 143 68 154 25 81 162 33 5
2026/2027302 17 19 63 203 0 0 0 0 0 0 0 0
Totale 3.186